Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 10;14(12):1574.
doi: 10.3390/biom14121574.

Enzymatic Synthesis of Biologically Active H-Phosphinic Analogue of α-Ketoglutarate

Affiliations

Enzymatic Synthesis of Biologically Active H-Phosphinic Analogue of α-Ketoglutarate

Vsevolod L Filonov et al. Biomolecules. .

Abstract

Amino acid analogues with a phosphorus-containing moiety replacing the carboxylic group are promising sources of biologically active compounds. The H-phosphinic group, with hydrogen-phosphorus-carbon (H-P-C) bonds and a flattened tetrahedral configuration, is a bioisostere of the carboxylic group. Consequently, amino-H-phosphinic acids undergo substrate-like enzymatic transformations, leading to new biologically active metabolites. Previous studies employing NMR-based metabolomic and proteomic analyses show that in Escherichia coli, α-KG-γ-PH (the distal H-phosphinic analogue of α-ketoglutarate) can be converted into L-Glu-γ-PH. Notably, α-KG-γ-PH and L-Glu-γ-PH are antibacterial compounds, but their intracellular targets only partially overlap. L-Glu-γ-PH is known to be a substrate of aspartate transaminase and glutamate decarboxylase, but its substrate properties with NAD+-dependent glutamate dehydrogenase (GDH) have never been investigated. Compounds containing P-H bonds are strong reducing agents; therefore, enzymatic NAD+-dependent oxidation is not self-evident. Herein, we demonstrate that L-Glu-γ-PH is a substrate of eukaryotic GDH and that the pH optimum of L-Glu-γ-PH NAD+-dependent oxidative deamination is shifted to a slightly alkaline pH range compared to L-glutamate. By 31P NMR, we observe that α-KG-γ-PH exists in a pH-dependent equilibrium of keto and germinal diol forms. Furthermore, the stereospecific enzymatic synthesis of α-KG-γ-PH from L-Glu-γ-PH using GDH is a possible route for its bio-based synthesis.

Keywords: H-phosphinic analogue of α-ketoglutarate; H-phosphinic analogues of glutamate; glutamate dehydrogenase; glutamate metabolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chemical structure of the compounds containing phosphonic and phosphinic groups. (a) Well-known phosphorus-containing compounds with pharmacological or herbicidal activity. (b) Compounds of interest in this study, i.e., H-phosphinic analogues of L-glutamate and α-ketoglutarate (L-Glu-γ-PH and α-KG-γ-PH), respectively, and phosphonic analogue of glutamate (D,L-Glu-γ-P5).
Figure 2
Figure 2
L-Glu-γ-PH is a low-affinity substrate of GDH. (a) Schematic representation of the oxidative deamination of L-Glu-γ-PH catalyzed by GDH, yielding α-KG-γ-PH. (b) Reactions (500 µL) were performed in Tris–HCl buffer (100 mM, pH 7.5) at 25 °C containing L-glutamate (10 mM) or L-Glu-γ-PH (10 mM) and NAD+ (5 mM) and initiated by addition of GDH (14 µg). Data are from a representative experiment.
Figure 3
Figure 3
pH dependence of the initial reaction rates of GDH reaction with L-glutamate, rac-L-Glu-γ-PH and L-Glu-γ-PH as substrates. (a) Comparison of L-glutamate with rac-L-Glu-γ-PH and L-Glu-γ-PH as GDH substrates at different pH values. Reactions (500 µL) were performed in Tris–HCl buffer (100 mM, pH 6.5–9.0) and Gly-NaOH buffer (100 mM, pH 9.0–11.0) at 25 °C containing L-glutamate (10 mM), rac-Glu-γ-PH (10 mM) or L-Glu-γ-PH (10 mM) and NAD+ (5 mM) and initiated by addition of GDH (14 µg). (b) pH dependence of the GDH reaction rate for rac-L-Glu-γ-PH and L-Glu-γ-PH (in detail). Results are means ± SD of n = 3 independent assays, representative of n = 3 independent experiments.
Figure 4
Figure 4
Enzymatic synthesis of α-KG-γ-PH from L-Glu-γ-PH using GDH. (a) The percentage of L-glutamate and L-Glu-γ-PH conversion into α-KG and α-KG-γ-PH, respectively, with/without buffer. Reactions (500 µL) were performed without buffer at pH 9.0 in a mixture containing L-glutamate (10 mM) or L-Glu-γ-PH (10 mM) and NAD+ (5 mM) at 25 °C, initiated by the addition of GDH (14 µg). A similar mixture in Tris–HCl buffer (100 mM, pH 9.0) was used as a control. Results are shown as means ± SD of n = 3 independent assays, representative of n = 3 independent experiments. (b) Accumulation of α-KG-γ-PH over time in preparative synthesis. Reaction (100 mL) was performed at 25 °C in a buffer-free system at pH 9.0 in a mixture containing L-Glu-γ-PH (10 mM) and NAD+ (5 mM) and initiated by addition of GDH (5 mg).
Figure 5
Figure 5
NMR spectra of α-KG-γ-PH existing in aqueous solution as an equilibrium mixture of keto (I) and dihydroxy (II) forms (equation on the top). Panels (A1A4): 1H-31P HMBC spectrum cut-away views containing 31P correlation cross-peaks with phosphorus-bound proton highlighted yellow in formulas above. Panel (B): 1H-decoupled 31P-31P NOESY spectrum displaying strong (I) and (II) exchange peaks (pointed by arrow marks). Note: vertical scale is common for all panels.
Figure 6
Figure 6
Chemical structures of α-amino-H-phosphinic (III) and α-aminophosphonic acids (IV) confronted with amino acids (in the middle). The H-phosphinic group possesses a hydrogen atom (highlighted in yellow) that allows this group to acquire a flattened tetrahedral geometry making it bioisostere of the carboxyl group.

Similar articles

References

    1. Cragg G.M., Newman D.J. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta. 2013;1830:3670–3695. doi: 10.1016/j.bbagen.2013.02.008. - DOI - PMC - PubMed
    1. Horsman G.P., Zechel D.L. Phosphonate biochemistry. Chem. Rev. 2017;117:5704–5783. doi: 10.1021/acs.chemrev.6b00536. - DOI - PubMed
    1. Yu X., Doroghazi J.R., Janga S.C., Zhang J.K., Circello B., Grifiin B.M., Labeda D.P., Metcalf W.W. Diversity and abundance of phosphonate biosynthetic genes in nature. Proc. Natl. Acad. Sci. USA. 2013;110:20759–20764. doi: 10.1073/pnas.1315107110. - DOI - PMC - PubMed
    1. Falagas M.E., Vouloumanou K., Samonis G., Vardakas K.Z. Fosfomycin. Clin. Microbiol. Rev. 2016;29:321–347. doi: 10.1128/CMR.00068-15. - DOI - PMC - PubMed
    1. Pines G., Oh E.J., Bassalo M.C., Choudhury A., Garst A.D., Fankhauser R.G., Eckert C.A., Gill R.T. Genomic deoxyxylulose phosphate reductoisomerase (DXR) mutations conferring resistance to the antimalarial drug fosmidomycin in E. coli. ACS Synth. Biol. 2018;7:2824–2832. doi: 10.1021/acssynbio.8b00219. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources